Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-06-17 @ 3:25 AM
Study NCT ID:
NCT01395420
Status:
COMPLETED
Last Update Posted:
2017-09-01
First Post:
2011-07-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma
Sponsor:
Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Phase 1 | View |
| None | open label | View |
| None | healthy male and female (post menopausal) volunteers | View |
| None | Pharmacokinetics | View |
| None | CAZ104 | View |
| None | Avibactam | View |
| None | Ceftazidime | View |
| None | open label, at least 2 different regimens, concentration of investigational … | View |